These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36553549)

  • 1. A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia.
    Huang K; Xie L; Wang F
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
    Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
    Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of a pyroptosis-related gene signature of clinical and biological value in acute myeloid leukaemia.
    Shao R; Wang H; Wang J; Lu S; He R; Lu Y
    Int Immunopharmacol; 2022 Jul; 108():108802. PubMed ID: 35569433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
    Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
    Front Immunol; 2021; 12():695865. PubMed ID: 34135913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer.
    Li L; Li Y; Lin J; Pang W
    Technol Cancer Res Treat; 2024; 23():15330338241277584. PubMed ID: 39155627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
    Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
    Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
    Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
    BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia.
    Pan J; Jiang Y; Li C; Jin T; Yu K; Jin Z
    Front Oncol; 2022; 12():898236. PubMed ID: 35756629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia.
    Zhou T; Qian K; Li YY; Cai WK; Yin SJ; Wang P; He GH
    Front Pharmacol; 2022; 13():951480. PubMed ID: 36034801
    [No Abstract]   [Full Text] [Related]  

  • 11. A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Xu Y; Wang Y
    J Ovarian Res; 2023 Sep; 16(1):196. PubMed ID: 37730669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.
    Zhu Y; He J; Li Z; Yang W
    BMC Bioinformatics; 2023 Feb; 24(1):37. PubMed ID: 36737692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel pyroptosis-related LncRNA signature with multiple significance in acute myeloid leukemia.
    Zhong G; Guo C; Shang Y; Cui Z; Zhou M; Sun M; Fu Y; Zhang L; Feng H; Chen C
    Front Genet; 2022; 13():1029717. PubMed ID: 36685973
    [No Abstract]   [Full Text] [Related]  

  • 14. The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients.
    Nie L; Zhang Y; You Y; Lin C; Li Q; Deng W; Ma J; Luo W; He H
    Hematology; 2022 Dec; 27(1):840-848. PubMed ID: 35924822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
    Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
    Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Gene Signature Comprising Seven Pyroptosis-Related Genes Predicts Prognosis in Pediatric Patients with Acute Myeloid Leukemia.
    He X; Jiang Y; Yu X; He F; Gao H
    Acta Haematol; 2022; 145(6):627-641. PubMed ID: 35933981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
    Front Genet; 2022; 13():838624. PubMed ID: 35928454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
    Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
    Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.